Skip over main navigation
  • Log in
  • Basket: (0 items)
Hepatitis Australia
Listen
  • Search
  • Instagram
  • Twitter
  • Facebook
  • YouTube
National Hepatitis Infoline
Menu
  • About us
    • Who we are
    • Our Team
    • Our Board
    • Our Members
    • Corporate documents
    • Our website
    • Contact Us
    • Support Hepatitis Australia
  • Hepatitis information
    • Liver Health
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Lived Experience Stories
    • Other Languages
  • How to get help
    • National Hepatitis Infoline
    • Your Rights and Responsibilities
    • For friends and family
    • Local hepatitis organisations
    • COVID-19
  • Our work
    • World Hepatitis Day
    • Australia's Biggest Quiz
    • Ending Hepatitis C Campaign
    • Hepatitis B Health + Law research partnership
    • National Hep C 50,000 Project
    • Parliamentary Event: We can eliminate hepatitis B!
    • Policy and Advocacy
    • Past campaigns
  • Workforce
    • Resources
    • Training Opportunities
  • News
    • Latest News
    • Media Releases
  • Admin
    • Log in
  • Basket: (0 items)

National Hep C 50,000 Project

The 50,000 Project is an innovative national partnership project to scale up testing and treatment to find 50,000 people living with hepatitis C by the end of 2022. In doing so, the 50,000 Project will be central in Australia achieving the 2022 national hepatitis C targets for testing and treatment.

Background:

All Australians living with hepatitis C should be given the opportunity to live free from hepatitis C and to engage in our national elimination mission.

Australia is ramping up its efforts to achieve its national hepatitis C testing and treatment targets. Australians who have not yet been reached in our hepatitis C national response are geographically, socially and demographically diverse and dispersed. It is acknowledged that a business-as-usual hepatitis C response will not be sufficient to reach this broad cohort and our goals.

In November 2020, the Hon Greg Hunt MP, Federal Minister for Health, committed to finding 50,000 people living with hepatitis C by the end of 2022. Mobilised around this shared commitment, a sector-led proposal was developed on how this could be achieved resulting in the establishment of the National Hepatitis C 50,000 Project with support from the Minister for Health, the Blood Borne Viruses and Sexually Transmissible Infections (BBVSTI) Standing Committee and the Australian Department of Health.

About the National Hepatitis C 50,000 Project:

Premised on health and geographic equity, the 50,000 Project seeks to concurrently scale up five pillars of activity in areas where concerted effort is needed and where treatment targets are at risk of being missed. The Project is consistent with existing priorities for action in the National Hepatitis C Strategy and the National Aboriginal and Torres Strait Islander BBV/STI Strategy.  

The pillars are inter-related and mutually reinforcing. By implementing all activities concurrently, there is scope to amplify their reach, reinforce messages, and increase engagements and outcomes. The activities leverage and scale up the existing service system, and local capabilities to enable engagement that is above and beyond ‘business-as-usual’.

The 50,000 Project represents a genuinely new national initiative involving more than 250 potential partners. Many stakeholders are gathered and well-positioned to undertake and support these activities that centre affected communities; leverage new technologies, existing expertise, and established networks; and represent a deep commitment to improving the health and wellbeing of people impacted by hepatitis C.

The Project is funded by the Australian Government Department of Health.

Project Pillar

Implementing Partners

National hepatitis C public education campaigns 

Hepatitis Australia

The Burnet Institute in partnership with NACCHO and AIVL

National program to scale up hepatitis C point of care testing

The Kirby Institute in partnership with Flinders University and National Reference Laboratory

Expanded hepatitis activity in primary care including case finding

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)

National Hepatitis C Infoline enhancement

Hepatitis Australia

Hepatitis C systems working group and project coordination and evaluation

Australian Department of Health & BBVSTI Standing Committee

 

Published: 2nd March, 2022

Updated: 6th August, 2022

Author: Hepatitis Australia

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Clinical Trials

    Clinical Trials

    You can search ClinTrial Refer for hepatitis B and hepatitis C clinical trials.

  • An open letter to Gavi: hepatitis B birth dose vaccine can’t wait

    An open letter to Gavi: hepatitis B birth dose vaccine can’t wait

    Hepatitis Australia has signed an open letter to Gavi urging them to start their hepatitis B birth dose campaign. Implementing this campaign would save countless lives.

  • Priority populations finally protected under NTs modernised Anti-Discrimination Act

    Priority populations finally protected under NTs modernised Anti-Discrimination Act

    The Northern Territory AIDS and Hepatitis Council (NTAHC) and the Australian Federation of AIDS Organisations (AFAO) congratulates the Northern Territory Government on passing these important amendments to the Anti-Discrimination Act.

  • Third National Elimination Forum Program

Related

  • Hepatitis B Health + Law research partnership

    Hepatitis B Health + Law research partnership

    New Health+Law research partnership to ensure greater support for people living with HIV and Hepatitis B.

  • Australia's Biggest Quiz

    Australia's Biggest Quiz

    Register now to attend a local community event or join online

  • National Hepatitis Infoline

    National Hepatitis Infoline

    The National Hepatitis Infoline provides confidential and free information on hepatitis B and hepatitis C.

Most read

  • No, you’re not being tested for hepatitis as part of a routine blood test

    No, you’re not being tested for hepatitis as part of a routine blood test

    Hepatitis B and C are the most common blood borne viruses in Australia but testing for them is not part of normal blood tests—you generally have to ask your doctor.

  • A cure for hepatitis C

    A cure for hepatitis C

    You can take medicine to cure your hepatitis C. The tablets are easy to take and work very well. Most people don't have any side-effects.

  • Living with hepatitis B: The myth of the healthy carrier

    Living with hepatitis B: The myth of the healthy carrier

    If you’ve been told that you are “just a healthy carrier”, read on for a myth-busting update from Dr Alice Lam.

  • What is hepatitis C?

    What is hepatitis C?

    Basic information about hepatitis C and how it can affect you.

  • Hepatitis B medicine

    Hepatitis B medicine

    Medicines for hepatitis B help you live well with the virus. Talk to your doctor about whether starting treatment is right for you.

  • Testing for hepatitis B

    Testing for hepatitis B

    Tests used to diagnose hepatitis B

  • Testing for hepatitis C

    Testing for hepatitis C

    Information about the tests used to diagnose hepatitis C (hep C) infection

  • Hepatitis B vaccination

    Hepatitis B vaccination

    Hepatitis B can be prevented with a safe and effective vaccine.

  • What is hepatitis B?

    What is hepatitis B?

    Basic information about hepatitis B transmission and how it affects people.

  • Hepatitis C symptoms

    Hepatitis C symptoms

    Symptoms of hepatitis C are not always obvious

Info

Hepatitis Australia is a registered charity. 
ABN: 38 442 686 487

© Copyright 2019 Hepatitis Australia.
All rights reserved.
View our copyright statement here

Helpful links

  • Contact us
  • Full sitemap
  • Accessibillity
  • Terms & conditions
  • Privacy policy
  • Login
  • Logout
  • Manager

Member sites

  • Australian Capital Territory
  • New South Wales
  • Northern Territory
  • South Australia
  • Victoria
  • Queensland
  • Western Australia
  • Tasmania 

Hepatitis Australia acknowledges the Traditional Owners and Custodians of the land, waters and community where we walk, live and work. We value Aboriginal and Torres Strait Islander cultures, traditions, views and ways of life and pay our respects to Elders past and present.

Information provided on this website is for general information only and not intended as medical advice. Hepatitis Australia encourages all readers to seek independent medical advice before making any decisions based on the information provided on this website.

Hepatitis Australia is a partner organisation of healthdirect Australia.


Images used on this site may include stock photos and the associated messaging may not represent the personal situation, views or beliefs of the people in the images.